pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›CENESTIN
drug · unknown
save

CENESTIN

Marketedupdated 3mo ago
by $ASPU ASPEN GROUP, INC.🔗 ChEMBL
Approved
community read0 votes

🐶 often sniffed alongside

top 2
  • tagApproval120 co-mentions · 30 sources
  • tagSmall Molecule60 co-mentions · 30 sources

Unknown drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 2 investigational indications.

targets

Estrogen receptor

all catalysts(30)

approval · 30
Mar 24, 1999
approval
$ASPU0.2893-0.26%
27y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Sep 7, 1999
approval
$ASPU0.2893-0.26%
27y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Nov 2, 1999
approval
$ASPU0.2893-0.26%
27y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Nov 8, 1999
approval
$ASPU0.2893-0.26%
27y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Nov 12, 1999
approval
$ASPU0.2893-0.26%
27y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Jan 7, 2000
approval
$ASPU0.2893-0.26%
27y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Jan 27, 2000
approval
$ASPU0.2893-0.26%
27y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Mar 13, 2000
approval
$ASPU0.2893-0.26%
26y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Aug 9, 2000
approval
$ASPU0.2893-0.26%
26y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Jul 20, 2001
approval
$ASPU0.2893-0.26%
25y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Sep 5, 2001
approval
$ASPU0.2893-0.26%
25y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Sep 5, 2001
approval
$ASPU0.2893-0.26%
25y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Sep 10, 2001
approval
$ASPU0.2893-0.26%
25y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Feb 8, 2002
approval
$ASPU0.2893-0.26%
25y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Feb 8, 2002
approval
$ASPU0.2893-0.26%
25y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Feb 22, 2002
approval
$ASPU0.2893-0.26%
25y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Mar 5, 2002
approval
$ASPU0.2893-0.26%
24y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Apr 29, 2002
approval
$ASPU0.2893-0.26%
24y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Jun 21, 2002
approval
$ASPU0.2893-0.26%
24y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Oct 18, 2002
approval
$ASPU0.2893-0.26%
24y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Nov 5, 2002
approval
$ASPU0.2893-0.26%
24y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Jan 28, 2004
approval
$ASPU0.2893-0.26%
23y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Feb 5, 2004
approval
$ASPU0.2893-0.26%
23y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Oct 28, 2004
approval
$ASPU0.2893-0.26%
22y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Mar 20, 2015
approval
$ASPU0.2893-0.26%
11y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Nov 1, 2017
approval
$ASPU0.2893-0.26%
9y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Nov 30, 2020
approval
$ASPU0.2893-0.26%
6y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Nov 30, 2020
approval
$ASPU0.2893-0.26%
6y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Feb 15, 2024
approval
$ASPU0.2893-0.26%
3y ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
Feb 12, 2026
approval
$ASPU0.2893-0.26%
6mo ago
CENESTIN (ESTROGENS, CONJUGATED SYNTHETIC A) — FDA approval
CENESTIN
→
view all 30 catalysts →

News(0)

no news has mentioned this drug yet

brand
CENESTIN
trade names
Cenestin, Synthetic conjugated estrogens a
generic
ESTROGENS, CONJUGATED SYNTHETIC A
MOA
Estrogen receptor agonist
indication
vaginitis
phase
marketed
Data sources
openFDA · ClinicalTrials.gov · OpenTargets
last refreshed 2m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?